tetradecanoylphorbol acetate has been researched along with menatetrenone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eguchi, Y; Fujimoto, K; Hamajima, H; Ide, Y; Kawaguchi, Y; Mizuta, T; Ozaki, I; Yamamoto, K; Zhang, H | 1 |
1 other study(ies) available for tetradecanoylphorbol acetate and menatetrenone
Article | Year |
---|---|
Inhibition of matrix metalloproteinase expression by menatetrenone, a vitamin K2 analogue.
Topics: Carcinoma, Hepatocellular; Humans; Liver Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; NF-kappa B; Protease Inhibitors; Protein Kinase C; Tetradecanoylphorbol Acetate; Transcription Factor AP-1; Vitamin K 2 | 2009 |